New COVID-19 Variant Mu identified by WHO

"The Mu variant has a constellation of mutations that indicate potential properties of immune escape," WHO said in its weekly pandemic bulletin.

Published On 2021-09-01 11:03 GMT   |   Update On 2021-09-01 11:03 GMT

Geneva: The World Health Organization has said it is monitoring a new coronavirus variant known as "Mu", which was first identified in Colombia in January.

Mu, known scientifically as B.1.621, has been classified as a "variant of interest", the global health body said Tuesday in its weekly pandemic bulletin.

Also Read: Third dose of COVID-19 vaccine strongly shields against Delta variant, says Pfizer data

The WHO said the variant has mutations that indicate a risk of resistance to vaccines and stressed that further studies were needed to better understand it.

"The Mu variant has a constellation of mutations that indicate potential properties of immune escape," the bulletin said.

There is widespread concern over the emergence of new virus mutations as infection rates are ticking up globally again, with the highly transmissible Delta variant taking hold -- especially among the unvaccinated -- and in regions where anti-virus measures have been relaxed.

All viruses, including SARS-CoV-2 that causes Covid-19, mutate over time and most mutations have little or no effect on the properties of the virus.

But certain mutations can impact the properties of a virus and influence how easily it spreads, the severity of the disease it causes, and its resistance to vaccines, drugs and other countermeasures.

The WHO currently identifies four Covid-19 variants of concern, including Alpha, which is present in 193 countries, and Delta, present in 170 countries.

Five variants, including Mu, are to be monitored.

After being detected in Colombia, Mu has since been reported in other South American countries and in Europe.

The WHO said its global prevalence has declined to below 0.1 percent among sequenced cases. In Colombia, however, it is at 39 percent.

Tags:    
Article Source : AFP

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News